Our three programs offer unique experiences to earn a medical degree. The University (Western Reserve 2) Program, our traditional four-year MD program, is our oldest and largest, offering an ...
In his second year of medical school at The University of Texas (UT) Health Science Center at San Antonio, Flitton is ...
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, ...
Secure, scalable, multi-cloud platform using federated learning aims to accelerate cancer discoveries and treatments SEATTLE, WASHINGTON / ACCESS Newswire / October 1, 2025 / The Cancer AI Alliance ...
New York, NY (September 30, 2025) – Researchers at the Mount Sinai Health System have identified specific ways in which addressing religion and spirituality during radiation therapy can play an ...
Patients treated with ulixacaltamide in the parallel-group study (Study 1) showed a mean improvement from baseline in the Modified Activities of ...
New York, NY [September 25, 2025]— A new study from researchers at the Mount Sinai Health System suggests that a simple tweak to how artificial intelligence (AI) assigns diagnostic codes could ...
The leaders of the MSK Lobular Breast Cancer program (from left), breast pathologist Fresia Pareja, MD, PhD; breast surgeon Anita Mamtani, MD; breast medical oncologist Sherry Shen, MD. The program is ...
Newspoint on MSN
Understanding the Path to Becoming a Mental Health Specialist: Psychologists vs. Psychiatrists
Exploring Careers in Mental Health Psychologist and Psychiatrist: In recent times, discussions surrounding mental health have ...
MyChesCo on MSN
Legislators Take Center Stage at Philadelphia Medical Cannabis Symposium, Linking Policy with Practice
PHILADELPHIA, PA — Pennsylvania legislative leaders will facilitate a forward-looking discussion on medical cannabis at the ...
Earlier this week, the National Cancer Institute (NCI) welcomed its 18th Director, the highly esteemed Dr. Anthony Letai. Dr. Letai, a graduate of Princeton University with a degree in Physics, ...
Emma Guttman, MD, PhD, discusses the promising potential of rocatinlimab in targeting the OX40-OX40 ligand pathway for atopic dermatitis treatment. Trial investigator Emma Guttman, MD, PhD, chair of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback